![Alex Thurman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 M $ al 31/07/2026
Alex R.
Thurman currently holds the positions of Chief Financial Officer & Senior Vice President at Glaukos Corp.
since 2022 and Vice President-Finance at Allergan UC since 2016.
Mr. Thurman completed undergraduate and graduate degrees at Brigham Young University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GLAUKOS CORP 0,08 % | 07/08/2026 | 43.906 ( 0,08 % ) | 7 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GLAUKOS CORPORATION | Director Financiero/CFO | 01/04/2022 |
| ALLERGAN PLC | Director Financiero/CFO | 01/12/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
